PANITUMUMAB

panitumumab 100 mg/5 mL injection, 5 mL vial

PANITUMUMAB (10508C)

10508C
Body System:
Manner of administration:Injection
Private
Chemotherapy Items for Private Hospital use
Authority Required (STREAMLINED)

Restriction  5526

Indication: Metastatic colorectal cancer
Treatment phase: Initial Treatment

Restriction  5452

Indication: Metastatic colorectal cancer
Treatment phase: Continuing treatment
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 720 mg # of repeats: 9 DPMA: $3,790.68 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Vectibix
(panitumumab 100 mg/5 mL injection, 5 mL vial)
Vectibix
(panitumumab 400 mg/20 mL injection, 20 mL vial)